Potential neuroprotective treatment of stroke: targeting excitotoxicity, oxidative stress, and inflammation
Q Yang, Q Huang, Z Hu, X Tang - Frontiers in neuroscience, 2019 - frontiersin.org
Stroke is a major cause of death and adult disability. However, therapeutic options remain
limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events …
limited. Numerous pathways underlie acute responses of brain tissue to stroke. Early events …
Pharmacotherapy of traumatic brain injury: state of the science and the road forward: report of the Department of Defense Neurotrauma Pharmacology Workgroup
R Diaz-Arrastia, PM Kochanek, P Bergold… - Journal of …, 2014 - liebertpub.com
Despite substantial investments by government, philanthropic, and commercial sources over
the past several decades, traumatic brain injury (TBI) remains an unmet medical need and a …
the past several decades, traumatic brain injury (TBI) remains an unmet medical need and a …
Cerebral edema in traumatic brain injury: pathophysiology and prospective therapeutic targets
EA Winkler, D Minter, JK Yue… - Neurosurgery …, 2016 - neurosurgery.theclinics.com
Traumatic brain injury (TBI) is a complex and heterogeneous disorder with a tremendous
public health burden. It is grossly defined as an alteration in brain function or other evidence …
public health burden. It is grossly defined as an alteration in brain function or other evidence …
Sulfonylurea receptor 1 in central nervous system injury: a focused review
JM Simard, SK Woo… - Journal of Cerebral …, 2012 - journals.sagepub.com
The sulfonylurea receptor 1 (Sur1)-regulated NCCa-ATP channel is a nonselective cation
channel that is regulated by intracellular calcium and adenosine triphosphate. The channel …
channel that is regulated by intracellular calcium and adenosine triphosphate. The channel …
Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke
E Besancon, S Guo, J Lok, M Tymianski… - Trends in pharmacological …, 2008 - cell.com
The glutamate receptor was one of the most intensely investigated targets for
neuroprotection. However, numerous clinical trials of glutamate receptor antagonists for the …
neuroprotection. However, numerous clinical trials of glutamate receptor antagonists for the …
Blood pressure and penumbral sustenance in stroke from large vessel occlusion
RW Regenhardt, AS Das, CJ Stapleton… - Frontiers in …, 2017 - frontiersin.org
The global burden of stroke remains high, and of the various subtypes of stroke, large vessel
occlusions (LVOs) account for the largest proportion of stroke-related death and disability …
occlusions (LVOs) account for the largest proportion of stroke-related death and disability …
[HTML][HTML] Endothelial sulfonylurea receptor 1–regulated NCCa-ATP channels mediate progressive hemorrhagic necrosis following spinal cord injury
JM Simard, O Tsymbalyuk, A Ivanov… - The Journal of …, 2007 - Am Soc Clin Investig
Acute spinal cord injury (SCI) causes progressive hemorrhagic necrosis (PHN), a poorly
understood pathological process characterized by hemorrhage and necrosis that leads to …
understood pathological process characterized by hemorrhage and necrosis that leads to …
Stress hyperglycemia and acute ischemic stroke in-hospital outcome
K Tziomalos, P Dimitriou, SD Bouziana, M Spanou… - Metabolism, 2017 - Elsevier
Abstract Background and Aims Stress hyperglycemia is frequent in patients with acute
ischemic stroke. However, it is unclear whether stress hyperglycemia only reflects stroke …
ischemic stroke. However, it is unclear whether stress hyperglycemia only reflects stroke …
Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview
Background Neuroprotection for ischemic stroke is a growing field, built upon the elucidation
of the biochemical pathways of ischemia first studied in the 1970s. Beginning in the early …
of the biochemical pathways of ischemia first studied in the 1970s. Beginning in the early …
[HTML][HTML] Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke
JM Simard, V Yurovsky, N Tsymbalyuk, L Melnichenko… - Stroke, 2009 - journals.lww.com
Background and Purpose—Ischemia/hypoxia induces de novo expression of the
sulfonylurea receptor 1-regulated NC (Ca-ATP) channel. In rodent models of ischemic …
sulfonylurea receptor 1-regulated NC (Ca-ATP) channel. In rodent models of ischemic …